Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status

Cell Host & Microbe(2022)10.1016/j.chom.2022.02.003Source: DataRank Database

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status is a research paper published in Cell Host & Microbe (2022). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: bronzeTopics (50)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Eric Wang ORCID,Emily Garrigan,Benjamin Goodwin ORCID,Aaron Sutherland ORCID,Alison Tarke ORCID

Live enrichment

PubMed:35172129 PMC:PMC8824221

National Institute of Allergy and Infectious Diseases

Grant: 5N9301900066

National Institute of Allergy and Infectious Diseases

Grant: 75N93019C00065

National Institute of Allergy and Infectious Diseases

Grant: U19 AI142742

NIAID NIH HHS

Grant: R25 AI147376

NIAID NIH HHS

Grant: R01 AI135193

NIAID NIH HHS

Grant: T32 AI007036

National Institutes of Health

Grant: 5U19AI142742-03

Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

National Institutes of Health

bronzeLicense: Elsevier Non-Commercial

publisherhttp://www.cell.com/article/S1931312822000890/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312822000890?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312822000890?httpAccept=text/plain

repositoryhttp://hdl.handle.net/11567/1074292

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8824221

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

HumansAntibodies, ViralEpitopes, T-LymphocyteVaccinationSpike Glycoprotein, CoronavirusCOVID-19SARS-CoV-2COVID-19 Vaccines

Keywords

VirusesT cellsEpitopeVaccinationBreakthrough InfectionImmunodiagnostic ToolCovid-19Sars-cov-2570COVID-19 VaccinesCoronavirusesImmunologyCoronaviruses Vaccines610Epitopes, T-LymphocyteAntibodies, ViralMicrobiologyAntibodiesArticleVaccine RelatedEpitopesHumansViralBiomedical and Clinical SciencesPreventionCoronaviruses Disparities and At-Risk PopulationsSpike GlycoproteinCoronavirusEmerging Infectious DiseasesInfectious DiseasesGood Health and Well Being3.4 VaccinesT-LymphocyteMedical MicrobiologyBiochemistry and cell biologybreakthrough infection; COVID-19; epitope; immunodiagnostic tool; SARS-CoV-2; T cells; vaccination; virusesSpike Glycoprotein, CoronavirusImmunizationInfectionBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health